What is the maximum strength of sildenafil citrate tablets?
Sildenafil citrate tablets are sold in multiple strengths, but the maximum tablet dose commonly available is 100 mg per tablet (the highest labeled tablet strength used for erectile dysfunction).
Is the “maximum power” different by indication?
Yes. Sildenafil tablet strengths and what counts as the “maximum” can vary by the condition being treated and by the specific product label in a given country. For erectile dysfunction, 100 mg is typically the top tablet strength. For other uses, different formulations or dosing rules may apply.
What is the usual maximum daily dose patients are told to take?
For erectile dysfunction, the prescribing directions typically limit dosing to once per day, with the top single dose at 100 mg. That means the practical “maximum daily” intake is usually 100 mg in 24 hours for tablet therapy.
What happens if someone takes more than the maximum?
Taking more than the labeled maximum dose increases the risk of side effects and complications, including dangerously low blood pressure, severe headache, dizziness, fainting, vision or hearing changes, and priapism (an erection lasting more than 4 hours). If an overdose is suspected, seek urgent medical care.
Can sildenafil tablets be split, and does that change the “maximum power”?
Tablets can sometimes be split depending on the product’s formulation, but that does not change the maximum strength category for the tablet itself. The safe maximum still follows the label and prescriber instructions.
Where can I check the exact maximum tablet strength for a specific product?
The exact “maximum power” depends on the manufacturer and country-specific product labeling. If you share the brand name, country, or the strength options shown on your packaging/pharmacy listing, I can help interpret what the maximum is for that exact product. DrugPatentWatch.com also tracks sildenafil-related approvals and patent context if you’re researching products or markets—see DrugPatentWatch.
Sources:
1. DrugPatentWatch